Hier vindt u een chronologisch overzicht van wetenschappelijke publicaties in 2016, gepubliceerd door de klinische onderzoeksgroepen die betrokken zijn bij ATHENA/SHM.

Advancing Migrant Access to Health Services in Europe (AMASE): Protocol for a Cross-sectional Study 
Fakoya I, on behalf of the aMASE Study Group
JMIR Res Protoc. 2016 Apr-Jun; 5(2): e74. Abstract

Cigarette smoking and inflammation, monocyte activation, and coagulation in HIV-infected individuals receiving antiretroviral therapy, compared with uninfected individuals 
Kooij KW, Wit FW, Booiman T, van der Valk M, Schim van der Loeff MF, Kootstra N, Reiss P; AGEhIV Cohort Study Group.
J Infect Dis. 2016 Dec 15;214(12):1817-1821 Abstract

Estimating HIV incidence and number of undiagnosed individuals living with HIV in the European Union/European Economic Area, 2015 
Pharris A, Quinten C, Noori T, Amato-Gauci AJ, van Sighem A , the ECDC HIV/AIDS Surveillance and Dublin Declaration Monitoring Networks 
Eurosurveillance, Volume 21, Issue 48, 01 December 2016 Article

Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project 
Ngo-Giang-Huong N,Wittkop L, Judd A, Reiss P, Goetghebuer T, Duiculescu D, Noguera-Julian A, Marczynska M, Giacquinto C, Ene L, Ramos JT, Cellerai C, Klimkait T, Brichard B, Valerius N, Sabin C, Teira R, Obel N, Stephan C, de Wit S, Thorne C, Gibb D, Schwimmer C, Campbell MA, Pillay D, Lallemant M; EuroCoord-CHAIN-EPPICC joint project study group. 
BMC Infect Dis. 2016 Nov 8;16(1):654 Abstract

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals 
Cain LE, Caniglia EC, Phillips A, Olson A, Muga R, Pérez-Hoyos S, Abgrall S, Costagliola D, Rubio R, Jarrín I, Bucher H, Fehr J, van Sighem A, Reiss P, Dabis F, Vandenhende MA, Logan R, Robins J, Sterne JA, Justice A, Tate J, Touloumi G, Paparizos V, Esteve A, Casabona J, Seng R, Meyer L, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration.
Medicine (Baltimore). 2016 Oct;95(41):e5133. Abstract

Chronic hepatitis B and C virus infection and risk for non-Hodgkin lymphoma in HIV-infected patients: A cohort study 
Wang Q, De Luca A, Smith C, Zangerle R, Sambatakou H, Bonnet F, Smit C, Schommers P, Thornton A, Berenguer J, Peters L, Spagnuolo V, Ammassari A, Antinori A, Roldan EQ, Mussini C, Miro JM, Konopnicki D, Fehr J, Campbell MA, Termote M, Bucher HC; Hepatitis Coinfection and Non Hodgkin Lymphoma project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. 
Ann Intern Med. 2016 Oct 18. doi: 10.7326/M16-0240. [Epub ahead of print] Abstract

The cardiovascular risk management for people living with HIV in Europe: how well are we doing? 
Shahmanesh M, Schultze A, Burns F, Kirk O, Lundgren J, Mussini C, Pedersen C, De Wit S, Kutsyna G, Mocroft A; EuroSIDA in EuroCOORD. 
AIDS. 2016 Oct 23;30(16):2505-2518. Abstract

Infection-related and -unrelated malignancies, HIV and the aging population. 
Shepherd L, Borges Á, Ledergerber B, Domingo P, Castagna A, Rockstroh J, Knysz B, Tomazic J, Karpov I, Kirk O, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD.
Shepherd L, Borges Á, Ledergerber B, Domingo P, Castagna A, Rockstroh J, Knysz B, Tomazic J, Karpov I, Kirk O, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD. Abstract

Reference curves for CD4+ T cell count response to combination of antiretroviral treatment in HIV-1 infected naïve patients 
Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R; Standard Reference Distribution of CD4 Response to HAART Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. 
HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12389. [Epub ahead of print] Abstract

Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. 
Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A; Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. 
HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12411. [Epub ahead of print] Abstract

Difference in aortic stiffness between treated middle-aged HIV Type 1-infected and uninfected individuals largely explained by traditional cardiovascular risk factors, with an additional contribution of prior advanced immunodeficiency. 
Kooij KW, Schouten J, Wit FW, van der Valk M, Kootstra NA, Stolte IG, van der Meer JT, Prins M, Grobbee DE, van den Born BJ, Reiss P. 
J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):55-62 Abstract

Kaposi sarcoma risk in HIV-infected children and adolescents on combination antiretroviral therapy from sub-Saharan Africa, Europe, and Asia 
Pediatric AIDS-Defining Cancer Project Working Group for IeDEA Southern Africa, TApHOD, and COHERE in EuroCoord.
Clin Infect Dis. 2016 Aug 30. pii: ciw519. [Epub ahead of print] Abstract

In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants. 
Denneman L, Cohen S, Godfried MH, van Leeuwen E, Nellen JF, Kuijpers TW, Pajkrt D, van de Plas A, Smit C, Weijsenfeld AM, Scherpbier HJ, Bunders MJ 
AIDS. 2016 Aug 24;30(13):2135-7. Abstract

Cause-specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy 
Trickey A, May MT, Vehreschild J, Obel N, Gill MJ, Crane H, Boesecke C, Samji H, Grabar S, Cazanave C, Cavassini M, Shepherd L, d'Arminio Monforte A, Smit C, Saag M, Lampe F, Hernando V, Montero M, Zangerle R, Justice AC, Sterling T, Miro J, Ingle S, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC). 
PLoS One. 2016 Aug 15;11(8):e0160460. doi: 10.1371/journal.pone.0160460. eCollection 2016.Abstract

Changing incidence and risk factors for Kaposi sarcoma by time since starting antiretroviral therapy: Collaborative analysis of 21 European cohort studies 
Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord. 
Clin Infect Dis. 2016 Aug 17. pii: ciw562. [Epub ahead of print] Abstract

Improved adipose tissue function with initiation of protease inhibitor-only ART 
Maughan RT, Feeney ER, Capel E, Capeau J, Domingo P, Giralt M, Lange JMA, Phanuphak P, Cooper DA, Reiss P, Mallon PWG. 
Journal of Antimicrobial Chemotherapy 2016; doi: 10.1093/jac/dkw301 Article

From clinical sample to complete genome: comparing methods for the extraction of HIV-1 RNA for high-throughput deep sequencing. 
Cornelissen M, Gall A, Vink M, Zorgdrager F, Binter Š, Edwards S, Jurriaans S, Bakker M, Ong SH, Gras L, van Sighem A, Bezemer D, de Wolf F, Reiss P, Kellam P, Berkhout B, Fraser C, van der Kuyl AC; BEEHIVE Consortium 
Virus Res. 2016 Aug 4. pii: S0168-1702(16)30403-8. doi: 10.1016/j.virusres.2016.08.004. [Epub ahead of print] Abstract

Renal impairment and cardiovascular disease in HIV-positive individuals; the D:A:D Study 
Ryom L, Lundgren JD, Ross M, Kirk O, Law M, Morlat P, Smit C, Fontas E, Fus CA, Hatleberg CI, de Wit S, Sabin C, Mocroft A, for the D:A:D study group 
J Infect Dis. (2016) doi: 10.1093/infdis/jiw342 Article

Virological and social outcomes of HIV-infected adolescents and young adults in the Netherlands before and after transition to adult care 
Weijsenfeld AM, Smit C, Cohen S, Wit FW, Mutschelknauss M, Van Der Knaap LC, van Zonneveld LM, Zomer BJ, Nauta N, Patist JC, Kuipers-Jansen MH, Smit EP, Blokhuis C, Pajkrt D; Dutch HIV adolescents and young adults (AYA) study group. 
Clin Infect Dis. 2016 Jul 20. pii: ciw487. [Epub ahead of print] Abstract

Associations between HIV-RNA-based indicators and virological and clinical outcomes. 
Laut KG, Shepherd LC, Pedersen C, Rockstroh JK, Sambatakou H, Paduta D, Matulionyte R, Smiatacz T, Mulcahy F, Lundgren JD, Mocroft A, Kirk O; EuroSIDA in EuroCoord. 
AIDS. 2016 Jul 31;30(12):1961-72. doi: 10.1097/QAD.0000000000001144. Abstract

Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey. 
Lazarus JV, Laut KG, Safreed-Harmon K, Peters L, Johnson M, Fätkenheuer G, Khromova I, Vandekerckhove L, Maciejewska K, Radoi R, Ridolfo AL, Mocroft A. 
BMC Infect Dis. 2016 Jul 20;16:335. doi: 10.1186/s12879-016-1685-x. Abstract

Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study 
Kamara DA, Smith C, Ryom L, Reiss P, Rickenbach M, Phillips A, Mocroft A, De Wit S, Law M, Monforte AD, Dabis F, Pradier C, Lundgren JD, Sabin C.
Antivir Ther. 2016;21(6):495-506. doi: 10.3851/IMP3051. Epub 2016 Apr 26 Abstract

The eye as a window to the brain: neuroretinal thickness is associated with microstructural white matter injury in HIV-infected children. 
Blokhuis C, Demirkaya N, Cohen S, Wit FW, Scherpbier HJ, Reiss P, Abramoff MD, Caan MW, Majoie CB, Verbraak FD, Pajkrt D. 
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3864-3871. doi: 10.1167/iovs.16-19716. Abstract

Patients' willingness to take multiple-tablet antiretroviral therapy regimens for treatment of HIV. 
Engelhard EA, Smit C, Vervoort SC, Smit PJ, Nieuwkerk PT, Kroon FP, Reiss P, Brinkman K, Geerlings SE. 
Drugs Real World Outcomes. eCollection 2016 Jun. 2016 May 2;3(2):223-230. Article

Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa 
Revell A, Khabo P, Ledwaba L, Emery S, Wang D, Wood R, Morrow C, Tempelman H, Hamers R, Reiss P, van Sighem A, Pozniak A, Montaner J, Lane HC, Larder B. 
Southern African Journal of HIV Medicine 2016;1(17). doi: 10.4102/hivmed.v17i1.450 Abstract

HIV and ageing: improving quantity and quality of life 
Althoff KN, Smit M, Reiss P, Justice AC. 
Curr Opin HIV AIDS. 2016 Jun 29. [Epub ahead of print] Abstract

An update to the HIV-TRePS system: The development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype 
Revell AD, Wand D, Wood R, Morrow C, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Nelson M, Montaner JSG, Lane HC, Larder Bam, on behalf of the RDI Data and Study Grou. 
Journal of Antimicrobial Chemotherapy 2016; doi: 10.1093/jac/dkw217 Abstract

Mortality according to CD4 count at start of combination antiretroviral therapy among HIV-infected patients followed for up to 15 years after start of treatment: Collaborative Cohort Study 
May MT, Vehreschild JJ, Trickey A, Obel N, Reiss P, Bonnet F, Mary-Krause M, Samji H, Cavassini M, Gill MJ, Shepherd LC, Crane HM, d'Arminio Monforte A, Burkholder GA, Johnson MM, Sobrino-Vegas P, Domingo P, Zangerle R, Justice AC, Sterling TR, Miró JM, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC). 
Clin Infect Dis. 2016 Jun 15;62(12):1571-7 Abstract

Changing utilization of stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study 
Podlekareva D, Grint D, Karpov I, Rakmanova A, Mansinho K, Chentsova N, Zeltina I, Losso M, Parczewski M, Lundgren JD, Mocroft A, Kirk O;EuroSIDA in EuroCoord. 
HIV Med. 2015 May 18. [Epub ahead of print] Abstract

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen 
De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D; CHAIN and COHERE in EuroCoord. 
J Antimicrob Chemother. 2016 May;71(5):1352-60 Abstract

Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine 
Kooij KW, Wit FW, Van Zoest RA, Schouten J, Kootstra N, Van Vugt M, Prins M, Reiss P, Van der Valk M; AGEhIV Cohort Study Group. 
AIDS. 2016 Apr 14. [Epub ahead of print] Abstract

White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on cART 
Su T, Wit FW, Caan MW, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB; AGEhIV Cohort Study. 
AIDS. 2016 May 5. [Epub ahead of print] Abstract

Higher prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and prior stavudine exposure 
van Zoest RA, Wit FW, Kooij KW, van der Valk M, Schouten J, Kootstra NA, Wiersinga WJ, Prins M, van den Born BH, Reiss P; AGEhIV Cohort Study Group. 
Clin Infect Dis. 2016 May 3. [Epub ahead of print] Abstract

T-cell activation independently associates with immune senescence in long-term antiretroviral drug-treated HIV-1-infected individuals 
Cobos Jiménez V, Wit FW, Joerink M, Maurer I, Harskamp AM, Schouten J, Prins M, van Leeuwen EM, Booiman T, Deeks SG, Reiss P, Kootstra NA; AGEhIV Study Group. 
J Infect Dis. 2016 Apr 12. pii: jiw146. [Epub ahead of print] Abstract

Neurometabolite alterations associated with cognitive performance in perinatally HIV-infected children 
Van Dalen YW, Blokhuis C, Cohen S, Ter Stege JA, Teunissen CE, Kuhle J, Kootstra NA, Scherpbier HJ, Kuijpers TW, Reiss P, Majoie CB, Caan MW, Pajkrt D. 
Medicine (Baltimore). 2016 Mar;95(12):e3093 Abstract

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration 
Sabin CA, Reiss P, Ryom L, Phillips AN, Weber R, Law M, Fontas E, Mocroft A, de Wit S, Smith C, Dabis F, d'Arminio Monforte A, El-Sadr W,Lundgren JD; D:A:D Study Group. 
BMC Med. 2016 Mar 31;14(1):61 Abstract

Structure and quality of outpatient care for people living with an HIV infection 
Engelhard EA, Smit C, Nieuwkerk PT, Reiss P, Kroon FP, Brinkman K, Geerlings SE. 
AIDS Care. 2016 Mar 13:1-11. [Epub ahead of print] Abstract

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study 
Rokx C, Gupta R, Rijnders B, Shafer B, Gregson J, Tang M, Hamers R, Raizes E, Crawford K, Marconi V, Hill A, Hosseinipour M, Clumeck N, Kanki P, Lockman S, Rinke de Wit T, Hoffman S, de Oliveira T, Wallis C, Morris L, Hunt G, Dunn D, Blanco JL, Gunthard H, Kumarasamy D, Kaleebu P, Pillay D, Charpentier C, Descamps D, van Damme A, Theys K, Camacho R, Calvez V, Gras L.
Lancet Infect Dis. 2016 May;16(5):565-75. doi: 10.1016/S1473-3099(15)00536-8. Abstract

HIV-associated neuroretinal disorder in patients with well-suppressed HIV-infection: A comparative cohort study. 
Demirkaya N, Wit FW, van Den Berg TJ, Kooij KW, Prins M, Schlingemann RO, Abramoff MD, Reiss P, Verbraak FD; AGEhIV Cohort Study Group.
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1388-97. Abstract

When to monitor CD4 cell count and HIV RNA to reduce mortality and AIDS-defining illness  in virologically suppressed HIV-positive persons on antiretroviral therapy in high-income countries: a prospective observational study 
HIV-CAUSAL Collaboration and the Center for AIDS Research Network of Integrated Clinical Systems. 
J Acquir Immune Defic Syndr. 2016 Feb 18. [Epub ahead of print] Abstract

Improvements over time in short-term mortality following myocardial infarction in the D: A: D Study 
Hatleberg CI, Ryom L, El-Sadr W, Smith C, Weber R, Reiss P, Fontas E, Dabis F, Law M, Monforte AD, De Wit S, Mocroft A, Phillips A, Lundgren JD, Sabin C; D:A:D Study Group. 
AIDS. 2016 Mar 4. [Epub ahead of print] Abstract

A method to estimate the size and characteristics of HIV-positive populations using an individual-based stochastic simulation model 
Nakagawa F, van Sighem A, Thiebaut R, Smith C, Ratmann O, Cambiano V, Albert J, Amato-Gauci A, Bezemer D, Campbell C, Commenges D, Donoghoe M, Ford D, Kouyos R, Lodwick R, Lundgren J, Pantazis N, Pharris A, Quinten C, Thorne C, Touloumi G, Delpech V, Phillips A; SSOPHIE project working group in EuroCoord. 
Epidemiology. 2016 Mar;27(2):247-256 Abstract

Prevalence and determinants of insufficient work ability in older HIV-positive and HIV-negative workers 
Möller LM, Brands R, Sluiter JK, Schouten J, Wit FW, Reiss P, Prins M, Stolte IG 
Int Arch Occup Environ Health. 2016 Jan 8. [Epub ahead of print] Abstract

Predictive value of prostate specific antigen in a European HIV-positive cohort: does one size fit all? 
Shepherd L, Borges ÁH, Ravn L, Harvey R, Bower M, Grulich A, Silverberg M, Kronborg G, Galli M, Kirk O, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD. 
Antivir Ther. 2016 Jan 29. doi: 10.3851/IMP3026. [Epub ahead of print] Abstract

Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naïve HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort 
Rokx C, Gras L, van de Vijver D, Verbon A, Rijnders B; ATHENA National Observational Cohort Study 
HIV Med. 2016 Feb 4. doi: 10.1111/hiv.12355. [Epub ahead of print] Abstract

Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals? 
Boettiger DC, Sabin CA, Grulich A, Ryom L, Bonnet F, Reiss P, Monforte AD, Kirk O, Phillips A, Bower M, Fätkenheuer G, Lundgren JD, Law M; Data collection on Adverse events of Anti-HIV Drugs (D:A:D) study group. 
AIDS. 2016 Feb 5. [Epub ahead of print] Abstract

Antiretroviral drugs and risk of chronic ALT elevation in HIV-monoinfected persons: The D:A:D Study 
Kovari H, Sabin CA, Ledergerber B, Ryom L, Reiss P, Law M, Pradier C, Dabis F, d'Arminio Monforte A, Smith C, de Wit S, Kirk O, Lundgren JD, Weber R, on on behalf of the D:A:D Study group 
"Open Forum Infect Dis (2016) doi: 10.1093/ofid/ofw009" Article

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1subtype B and non-subtype B receiving a salvage regimen 
De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D; CHAIN and COHERE in EuroCoord. 
J Antimicrob Chemother. 2016 Jan 28. pii: dkv465. [Epub ahead of print] Abstract

White matter structure alterations in HIV-1-infected men with sustained suppression of viraemia on treatment. 
Su T, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Cole JH, Sharp DJ, Vos FM, Prins M, Portegies P, Reiss P, Majoie CB; AGEhIV Cohort Study.
AIDS. 2016 Jan;30(2):311-22 Abstract

Missed opportunities to offer HIV tests to high-risk groups during general practitioners' STI-related consultations: an observational study 
Joore IK, Reukers DF, Donker GA, van Sighem AI, Op de Coul EL, Prins JM, Geerlings SE, Barth RE, van Bergen JE, van den Broek IV 
BMJ Open. 2016 Jan 21;6(1):e009194. Abstract

Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the Netherlands 
Engelhard EA, Smit C, Van Sighem A, Reiss P, Nieuwkerk PT, Kroon FP, Brinkman K, Geerlings SE 
AIDS. 2016 Jan;30(2):301-10. Abstract

Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohort 
Op de Coul EL, van Sighem A, Brinkman K, Benthem BH, Ende ME, Geerlings S, Reiss P; ATHENA national observational HIV cohort 
AIDS. 2016 Jan;30(2):301-10. Abstract

HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls 
Kooij KW, Wit FW, Schouten J, van der Valk M, Godfried MH, Stolte IG, Prins M, Falutz J, Reiss P; AGEhIV Cohort Study Group 
AIDS. 2016 Jan;30(2):241-50 Abstract

Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy 
Schouten J, Su T, Wit FW, Kootstra NA, Caan MW, Geurtsen GJ, Schmand BA, Stolte IG, Prins M, Majoie CB, Portegies P, Reiss P; AGEhIV Study Group. 
AIDS. 2016 Jan 8. [Epub ahead of print] Abstract

Sources of HIV infection among men having sex with men and implications for prevention 
Ratmann O, van Sighem A, Bezemer D, Gavryushkina A, Jurriaans S, Wensing A, de Wolf F, Reiss P, Fraser C; ATHENA observational cohort. 
Sci Transl Med. 2016 Jan 6;8(320):320ra2 Abstract

Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons 
Ryom L, Lundgren JD, De Wit S, Kovari H, Reiss P, Law M, El-Sadr W, Monforte AD, Mocroft A, Smith C, Fontas E, Dabis F, Phillips A, Sabin C; D:A:D Study Group. 
AIDS 2016 Jan 8 [Epub ahead of print] Abstract

Impact of body weight on virological and immunological responses to efavirenz-containing regimes in HIV-infected, treatment-naive adults 
Marzolini C, Sabin C, Raffi F, Siccardi M, Mussini C, Launay O, Burger D, Roca B, Fehr J, Bonora S, Mocroft A, Obel N, Dauchy FA, Zangerle R, Gogos C, Gianotti N, Ammassari A, Torti C, Ghosn J, Chêne G, Grarup J, Battegay M; Efavirenz, Obesity Project Team on behalf of Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
AIDS. 2015 Jan 14;29(2):193-200 Abstract